Repository

• Home
• Repository
• Publications

Publications

From barriers to solutions: an expert-based algorithm for cholangiocarcinoma and other biliary tract cancers testing in the Era of precision oncology Stenzinger A, Normanno N, Lamarca A, Rimassa L, Bibeau F, Taniere P, Vogel A, Hollebecque A. Expert Rev Mol Diagn . 2025 Aug;25(8):495-508. doi: 10.1080/14737159.2025.2521538 2025  Result from

A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC-D Index Persano M, Rimini M, Salani F, Prinzi FL, Nichetti F, Saborowski A, Antonuzzo L, Passeri L, Satake T, Peeters F, Vivaldi C, Pressiani T, Lucchetti J, Kim JW, Abidoye O, Corallo S, Rapposelli IG, Tamberi S, Finkelmeier F, Giordano G, Pircher C, Chon HJ, Braconi C, Qaisar A, Pirrone C, Castet F, Tamburini E, Yoo C, Parisi A, Diana A, Scartozzi M, Prager GW, Avallone A, Schirripa M, Kim IH, Perkhofer L, Oneda E, Verrico M, Couto N, Adeva J, Chan SL, Spinelli GP, Personeni N, Garajova I, Rodriquenz MG, Leo S, Alvim CM, Roque R, Farinea G, Fornaro L, De Rosa A, Lanzetta I, Balsano R, Lavacchi D, Camera S, Ikeda M, Dekervel J, Niger M, Tesini G, Tonini G, Kang M, Bekaii-Saab T, Esposito L, Boccaccino A, Ferrara M, Himmelsbach V, Landriscina M, Djaballah SA, Masi G, Vogel A, Lonardi S, Rimassa L, Casadei-Gardini A. Liver Int. 2025 Jul;45(7):e70181. doi: 10.1111/liv.70181. 2025  Result from

Refinement of histologic subtypes and identification of biomarkers linked to unfavorable prognosis in cholangiocarcinoma: The ENSCCA registries' framework for digital twin advancement Carpino G, Overi D, Macias RI, Cardinale V, Izquierdo-Sanchez L, Acedo P, Rengo M, Doukas M, Kendall TJ, Calderaro J, Heij LR, Reichel K, Leone S, Onori P, Franceschini B, Soldani C, Di Tommaso L, Rodrigues PM, Augustin J, Brustia R, Torzilli G, Martin-Izquierdo M, Hernández-Bayo JM, Bueno-Sacristan D, Lanza E, Garcia-Sampedro A, Quaglia A, Ardito F, De Rose AM, Giuliante F, Damato E, Panebianco V, Groot Koerkamp B, Pereira SP, Grazi GL, Alvaro D, Lleo A, Banales JM, Gaudio E Hepatology. 2025 Jun 16. doi: 10.1097/HEP.0000000000001425 2025  Result from   OA Funded by

Modulating Wnt/β-catenin pathway activity to enhance chemosensitivity in cholangiocarcinoma Delgado-Calvo K, Boulter L, Briz O, Rozyczko A, Olaizola P, Marin JJG, Macias RIR, Lozano E Biomed Pharmacother. 2025 Jul;188:118225. doi: 10.1016/j.biopha.2025.118225 2025  Result from

Factors associated with reaching maintenance therapy in patients with advanced biliary tract cancer treated with durvalumab: Real-world results from a multicenter and multinational study Rimini M, Fornaro L, Prinzi FL, Rizzato MD, Saborowski A, Antonuzzo L, Rossari F, Satake T, Peeters F, Vivaldi C, Pressiani T, Lucchetti J, Kim JW, Abidoye O, Rapposelli IG, Tamberi S, Finkelmeier F, Giordano G, Pircher C, Chon HJ, Braconi C, Qaisar A, Pirrone C, Castet F, Tamburini E, Yoo C, Parisi A, Diana A, Scartozzi M, Prager GW, Avallone A, Schirripa M, Kim IH, Perkhofer L, Oneda E, Verrico M, Couto N, Adeva J, Chan SL, Spinelli GP, Personeni N, Garajova I, Rodriquenz MG, Leo S, Alvim CM, Roque R, Farinea G, Salani F, De Rosa A, Lavacchi D, Camera S, Ikeda M, Dekervel J, Niger M, Balsano R, Tonini G, Corallo S, Kang M, Bekaii-Saab T, Esposito L, Boccaccino A, Vitiello F, Himmelsbach V, Landriscina M, Djaballah SA, Tesini G, Masi G, Vogel A, Lonardi S, Rimassa L, Casadei-Gardini A. Int J Cancer . 2025 Sep 15;157(6):1246-1259. doi: 10.1002/ijc.35481 2025  Result from